Page results
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
Find more information on bites, stings and animal related injuries.
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
-
Mr Laurence Watkins is a consultant neurosurgeon with sub-speciality interests in hydrocephalus, neurovascular surgery, intracranial pressure, chronic headache and neuro-endoscopy
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
Mr Jonathan Hyam is a consultant neurosurgeon who has an interest in headache, facial pain, movement disorders, and spinal pain.
-
With all eyes on Paris for this summer’s Olympic Games, we look at how UCLH’s Institute of Sport, Health and Exercise (ISEH) has supported one of Britian’s Olympic hopefuls, and the care it provides for all kinds of sportspeople, from professionals to weekend warriors.
-
UCLH is making a commitment to reduce its impact on the environment with a 10-point plan to reach net zero carbon dioxide emissions in 10 years.
File results
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0041 - International recruitment